Addus HomeCare Corp. (ADUS) is a publicly traded Healthcare sector company. As of September 8, 2026, ADUS trades at $118.91 with a market cap of $2.22B and a P/E ratio of 27.43. ADUS moved +0.51% today. Year to date, ADUS is +10.59%; over the trailing twelve months it is +4.89%. Its 52-week range spans $87.95 to $136.72. Analyst consensus is buy with an average price target of $127.43. Rallies surfaces ADUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ADUS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $118.91 |
| Market Cap | $2.22B |
| P/E Ratio | 27.43 |
| EPS | $4.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $136.72 |
| 52-Week Low | $87.95 |
| Volume | 61.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15B |
| Net Income | $73.60M |
| Gross Margin | 32.48% |
9 analysts cover ADUS: 0 strong buy, 7 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $127.43.